4//SEC Filing
Aralez Pharmaceuticals Inc. 4
Accession 0001104659-17-032407
CIK 0001660719operating
Filed
May 11, 8:00 PM ET
Accepted
May 12, 9:50 PM ET
Size
7.6 KB
Accession
0001104659-17-032407
Insider Transaction Report
Form 4
Fowler Neal Franklin
Director
Transactions
- Award
Common Shares, without par value
2017-05-11+7,500→ 73,869 total - Award
Director Stock Option (right to buy)
2017-05-11+15,000→ 15,000 totalExercise: $1.56Exp: 2027-05-11→ Common Shares, without par value (15,000 underlying)
Footnotes (3)
- [F1]Restricted Stock Units, all of which vest on May 11, 2018, subject to the director's continued service on the Board as of such date. Vested shares will be delivered to the Reporting Person on the earlier of the date that the Reporting Person ceases to provide services to the Board and the date of a Change of Control, as defined in the Issuer's 2016 Amended and Restated Long-Term Incentive Plan, in either case provided that the Restricted Stock Units are vested on such date.
- [F2]Includes 66,369 shares of Common Stock and 7,500 Restricted Stock Units.
- [F3]The option vests in one installment on May 11, 2018, subject to the director's continued service on the Board as of such date.
Documents
Issuer
Aralez Pharmaceuticals Inc.
CIK 0001660719
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001660719
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 9:50 PM ET
- Size
- 7.6 KB